{"id":732349,"date":"2023-02-16T16:23:24","date_gmt":"2023-02-16T21:23:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/"},"modified":"2023-02-16T16:23:24","modified_gmt":"2023-02-16T21:23:24","slug":"singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/","title":{"rendered":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Feb.  16, 2023  (GLOBE NEWSWIRE) &#8212; Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p align=\"justify\">Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tI-fGT48mv2AyiTg7uQpIBSFVjjHijGDA1YNUSSel7HuZI-jPGH0gQkZzaZTVtk3awm3ng0CgZvwejEIHz5aqjsCLebmuN1vF05tB87BkLqkefP6jj0QyDoWGg7xHaUM\" rel=\"nofollow noopener\" target=\"_blank\">investor.singulargenomics.com<\/a>, in the Presentations &amp; Events section.<\/p>\n<p align=\"justify\">\n        <strong>About Singular Genomics Systems, Inc. <\/strong><br \/>\n        <br \/>Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular\u2019s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics\u2019 mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Matt Clawson<br \/>949-370-8500<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aBgDs_f1FCE5pNfJUF8zeJQsj2GBoUsf9UbY25UTd3IB6gNypcoolyTWlF_FMLHtgL_STwKJ6BL8ELxi4H51xRUEuZp0A940VIC-rRv5ejQ=\" rel=\"nofollow noopener\" target=\"_blank\">ir@singulargenomics.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Dan Budwick, 1AB<br \/>973-271-6085<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B9BSbAwnR3l6MEW44melpXVMQ2Ky1XOnOKlU4ks4SSPxZA65wJli2iNatrdbQZS5T1JoWtDfyX8OFhzR3wnVdw==\" rel=\"nofollow noopener\" target=\"_blank\">dan@1abmedia.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDQ5MWUxMzAtNTBlZi00NWU3LWIyMzItMmVmZDNhNzhkYjliLTEyMjA5ODg=\/tiny\/Singular-Genomics-Systems-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) &#8212; Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations &amp; Events section. About Singular Genomics Systems, Inc. Singular Genomics is a life science technology company that develops next-generation sequencing and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-732349","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) &#8212; Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations &amp; Events section. About Singular Genomics Systems, Inc. Singular Genomics is a life science technology company that develops next-generation sequencing and &hellip; Continue reading &quot;Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T21:23:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023\",\"datePublished\":\"2023-02-16T21:23:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/\"},\"wordCount\":221,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/\",\"name\":\"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\",\"datePublished\":\"2023-02-16T21:23:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/","og_locale":"en_US","og_type":"article","og_title":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk","og_description":"SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) &#8212; Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations &amp; Events section. About Singular Genomics Systems, Inc. Singular Genomics is a life science technology company that develops next-generation sequencing and &hellip; Continue reading \"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-16T21:23:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023","datePublished":"2023-02-16T21:23:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/"},"wordCount":221,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/","name":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=","datePublished":"2023-02-16T21:23:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MDQzNyM1NDEyNzA2IzIyMDk0MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/singular-genomics-to-report-fourth-quarter-2022-financial-results-on-march-2-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=732349"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732349\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=732349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=732349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=732349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}